SCHEMBL29970296

SCHEMBL29970296

C[N+](C)(C)CC(O)(CC(=O)[O-])C(=O)C=CCC(=O)O

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.35
BBOX1 O75936 1/20 0.33
ALDH1A1 P00352 1/20 0.32
CYP2D6 P10635 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30758921 0.84 CA4 (0.37) CA4BBOX1
SCHEMBL29540929 0.83 CA4 (0.38) CA4BBOX1
SCHEMBL31596793 0.82 CA4 (0.35) CA4BBOX1
SCHEMBL31121005 0.81 CA4 (0.39) CA4BBOX1
SCHEMBL29396627 0.78 FABP3 (0.43)
SCHEMBL31621795 0.78 FABP3 (0.43)
SCHEMBL31536290 0.77 FABP3 (0.45)
SCHEMBL31570935 0.77 FABP3 (0.45)
SCHEMBL31031110 0.77 FABP3 (0.45)
SCHEMBL31151848 0.77 FABP3 (0.33) CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11493516-B2 Biomarkers for assessing breast cancer METABOLOMYCS, INC (US) 2022-11-08 US disclosed